EUVIMEDEUVIMED entdecken
Crossref

Thymectomy in thymomatous generalized myasthenia gravis: An analysis of the prognosis and risk factors

Jinwei Zhang iD, Peng Zhang iD, Hui Zhang, Yuantao Cui, Yuan Chen, Peng Lv, Xin Li, Peng Zhang iD

European Journal of Neurology · 2023

DOI: 10.1111/ene.15807 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, 2023. Verfasst von Jinwei Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Tianjin Medical University General Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Myasthenia Gravis, Thymus Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose This study investigated the postthymectomy outcomes and factors affecting the prognosis of thymomatous generalized myasthenia gravis (TGMG).

Methods

Clinical records of 86 patients with TGMG who underwent thymectomy at our institution between 2012 and 2020 were retrospectively reviewed. Predictors of complete stable remission (CSR) and exacerbation were analyzed using multivariate regression analysis.

Results

A total of 16 patients achieved CSR, four achieved pharmacological remission, six exhibited deterioration, and eight died of myasthenia gravis (MG; mean follow‐up = 75.1 months). Male sex ( p = 0.049) and disease duration < 11.5 weeks before surgery ( p = 0.003) were significant positive predictors of CSR. Onset age < 52.8 years and symptoms of ocular and limb muscle weakness had a higher CSR rate than onset age > 52.8 years ( p = 0.056) and symptoms of bulbar muscles ( p = 0.071). Female patients had a significant higher risk of exacerbation ( p = 0.042).

Conclusions

Male sex and disease duration < 11.5 weeks were independent predictors of CSR in TGMG postthymectomy. Onset age < 52.8 years and ocular and limb muscle weakness at onset were associated with a higher probability of achieving CSR than onset age > 52.8 years and bulbar muscle weakness. Female sex was an independent predictor of MG symptom exacerbation in TGMG postthymectomy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myasthenia GravisThymus NeoplasmsHumansMaleFemaleMiddle AgedThymectomyTreatment OutcomeRetrospective StudiesPrognosisRisk FactorsMuscle Weakness

Stichwörter der Autor:innen

exacerbationgeneralized myasthenia gravisremissionthymectomythymoma

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery, Tianjin Medical University General Hospital, Tianjin, China.

ORCID-Profile: Jinwei Zhang, Peng Zhang, Peng Zhang

Zitieren

APA

Zhang, J., Zhang, P., Zhang, H., Cui, Y., Chen, Y., Lv, P., Li, X., & Zhang, P. (2023). Thymectomy in thymomatous generalized myasthenia gravis: An analysis of the prognosis and risk factors. European Journal of Neurology. https://doi.org/10.1111/ene.15807

Vancouver

Zhang J, Zhang P, Zhang H, Cui Y, Chen Y, Lv P, et al. Thymectomy in thymomatous generalized myasthenia gravis: An analysis of the prognosis and risk factors. European Journal of Neurology. 2023. doi:10.1111/ene.15807

BibTeX
@article{Zhang2023,
  author = {Zhang, Jinwei and Zhang, Peng and Zhang, Hui and Cui, Yuantao and Chen, Yuan and Lv, Peng and Li, Xin and Zhang, Peng},
  title = {Thymectomy in thymomatous generalized myasthenia gravis: An analysis of the prognosis and risk factors},
  journal = {European Journal of Neurology},
  year = {2023},
  doi = {10.1111/ene.15807}
}
Kostenlos starten →